Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Cardiac complications after SCT

Christopher Dandoy, MD, MSc, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, discusses cardiac complications following stem cell transplantation (SCT), highlighting the importance of identifying patients at risk of cardiac toxicity and mitigating these complications. Dr Dandoy explains that cardiac complications often arise as a result of thrombotic microangiopathy (TMA) following SCT. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.